Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0A059QQZ5
|
NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3;
|
ND1;
|
NULL
|
318
|
human
|
Q59FP5
|
Spectrin, beta, erythrocytic (Includes spherocytosis, clinical type I) variant; Fragment;
|
NULL
|
NP_000338.3;NP_001020029.1;
|
2332
|
human
|
Q9BCS6
|
MHC class II antigen; Fragment;
|
HLA-DRB1;
|
NULL
|
89
|
human
|
Q6PK95
|
TOP1 protein; Fragment;
|
TOP1;
|
NULL
|
164
|
human
|
Q6PKA6
|
ALDH3A1 protein; Fragment;
|
ALDH3A1;
|
NP_000682.3;
|
512
|
human
|
Q6ZNU2
|
cDNA FLJ27147 fis, clone SPL09574, highly similar to B-lymphocyte antigen CD19;
|
NULL
|
NULL
|
363
|
human
|
A0A059QPN2
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
Q3C1X0
|
Putative uncharacterized protein;
|
NULL
|
NULL
|
54
|
human
|
A5XEI7
|
Guanine nucleotide-releasing factor 2; Fragment;
|
RAPGEF1;
|
NULL
|
126
|
human
|
Q5JPJ9
|
Putative uncharacterized protein DKFZp686D0114;
|
DKFZp686D0114;
|
NULL
|
294
|
human
|
Q6H2G8
|
Natural killer cell inhibitory receptor; Fragment;
|
KIR2DS2;
|
NULL
|
296
|
human
|
Q96AH6
|
NARG1L protein; Fragment;
|
NARG1L;
|
NULL
|
20
|
human
|
Q8N352
|
NARG1L protein; Fragment;
|
NARG1L;
|
NULL
|
501
|
human
|
A0A059QJR3
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
Q59GH5
|
COP9 signalosome subunit 5 variant; Fragment;
|
NULL
|
NULL
|
276
|
human
|
Q96FU4
|
Uncharacterized protein;
|
NULL
|
NULL
|
40
|
human
|
Q9HBU4
|
Caspase 8 isoform i; Fragment;
|
NULL
|
NULL
|
12
|
human
|
Q4LE58
|
EIF4G1 variant protein; Fragment;
|
EIF4G1; variant; protein;
|
NULL
|
1624
|
human
|
Q9UE95
|
Leucocyte antigen B; Fragment;
|
HLA-B;
|
NULL
|
181
|
human
|
Q59GL2
|
KIAA0367 protein variant; Fragment;
|
NULL
|
NULL
|
72
|
human
|